Plus, ASGE Special Interest Group meeting to also highlight Endoluminal Therapy for GERD EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that the company will host an educational...
SAGES Board of Governors reviewed and approved statement REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), is pleased to announce that based on clinical evidence, the Board of...
EndoGastric Solutions® Provides Access to the TIF 2.0 procedure through Medicare Administrative Contractor Palmetto GBA REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), is...
Three-year follow up data from the TEMPO randomized controlled trial supports evidence of TIF procedure as an effective, long-term treatment option for GERD REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for...
